Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA5 | P22460 | 4/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.47 |
| ▸ | KCNE1 | P15382 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.42 |
| ▸ | SCN1A | P35498 | 1/20 | 0.42 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.42 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | KCNJ5 | P48544 | 1/20 | 0.39 |
| ▸ | KCNJ3 | P48549 | 1/20 | 0.39 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4727087 | 0.95 | KCNA5 (0.49) | KCNA5KCNH2CYP2D6KCNE1TSHR | |
| SCHEMBL30664037 | 0.95 | KCNA5 (0.49) | KCNA5KCNH2CYP2D6KCNE1TSHR | |
| SCHEMBL1246137 | 0.93 | KCNA5 (0.47) | KCNA5KCNH2CYP2D6KCNE1TSHR | |
| SCHEMBL1246142 | 0.93 | KCNA5 (0.47) | KCNA5KCNH2CYP2D6KCNE1TSHR | |
| SCHEMBL1244305 | 0.93 | KCNA5 (0.47) | KCNA5KCNH2CYP2D6KCNE1TSHR | |
| SCHEMBL24920226 | 0.93 | KCNA5 (0.47) | KCNA5KCNH2CYP2D6KCNE1TSHR | |
| SCHEMBL1245544 | 0.93 | KCNA5 (0.47) | KCNA5KCNH2CYP2D6KCNE1TSHR | |
| SCHEMBL6114690 | 0.93 | KCNA5 (0.47) | KCNA5KCNH2CYP2D6KCNE1TSHR | |
| SCHEMBL1246211 | 0.93 | KCNA5 (0.47) | KCNA5KCNH2CYP2D6KCNE1TSHR | |
| SCHEMBL30664039 | 0.93 | KCNA5 (0.47) | KCNA5KCNH2CYP2D6KCNE1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102940224-B | Cinnamic acid acid amides is as delicious flavor substance | SYMRISE AG (DE) | 2016-05-04 | — | — | CN | claimed |
| CN-104361997-A | DSC battery manufacturing electrolyte solution | UNIV ZHEJIANG SCIENCE & TECH | 2015-02-18 | — | — | CN | claimed |
| CN-102940224-A | Cinnamamides as savory flavorings | SYMRISE AG | 2013-02-27 | — | — | CN | claimed |
| CN-101980620-A | Product for changing taste | FIRMENICH & CIE | 2011-02-23 | — | — | CN | claimed |
| CN-101980619-A | Taste modifying product | FIRMENICH & CIE | 2011-02-23 | — | — | CN | claimed |
| CN-118861562-A | Novel food additive dosage allocation method and system based on safety analysis | 六安文俊食品贸易有限公司 | 2024-10-29 | — | — | CN | disclosed |
| CN-118027254-A | Isobutylene pyridine salt ionic polymer, preparation method and application thereof, and antibacterial high polymer material | 中国石油化工股份有限公司 | 2024-05-14 | — | — | CN | disclosed |
| WO-2023183652-A1 | DUAL CXCR4-BTK INHIBITORS | X4 PHARMACEUTICALS, INC. (US) | 2023-09-28 | — | — | WO | disclosed |
| WO-2023107689-A1 | METHODS FOR TREATING PRIMARY IMMUNODEFICIENCY | X4 PHARMACEUTICALS, INC. (US) | 2023-06-15 | — | — | WO | disclosed |
| US-20230128195-A1 | SYNTHESIS OF HALICHONDRINS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2023-04-27 | — | — | US | disclosed |
| US-11548898-B2 | Synthesis of halichondrins | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2023-01-10 | — | — | US | disclosed |
| EP-4098261-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF NONALCOHOLIC STEATOHEPATITIS | Dong-A ST Co., Ltd. (KR) | 2022-12-07 | — | — | EP | disclosed |
| CN-102888200-A | Adhesive and adhesive sheet | LINTEC CORP | 2013-01-23 | — | — | CN | disclosed |
| CN-102482197-A | Process for producing diquaternary ammonium salt and novel intermediate | WAKO PURE CHEM IND LTD | 2012-05-30 | — | — | CN | disclosed |
| CN-102482208-A | Ionic Liquid Containing Allyl Sulfonate Anion | WAKO PURE CHEM IND LTD | 2012-05-30 | — | — | CN | disclosed |
| CN-101980620-A | Product for changing taste | FIRMENICH & CIE | 2011-02-23 | — | — | CN | disclosed |
| CN-101980619-A | Taste modifying product | FIRMENICH & CIE | 2011-02-23 | — | — | CN | disclosed |
| US-20110023483-A1 | Drive unit and method for its operation | VOITH PATENT GMBH (DE) | 2011-02-03 | — | — | US | disclosed |
| US-4113645-A | QUATERNARY AMMONIUM SALT DISPERSANT | POLAK'S FRUTAL WORKS, INC. (US) | 1978-09-12 | — | — | US | disclosed |
| US-4071746-A | Alkylbenzyl pyridinium compounds and uses | PETROLITE CORPORATION (US) | 1978-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11548898-B2 | Synthesis of halichondrins | H1-3, NISCH, H1-5 | KCNA5 923/4885KCNH2 762/4885CYP2D6 2658/4885 |
| US-20230128195-A1 | SYNTHESIS OF HALICHONDRINS | H1-3, NISCH, HDAC11 | KCNA5 926/4885KCNH2 761/4885CYP2D6 2623/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.